Carolyn S Calfee, MD
Critical Care (Intensivists) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 27 years
- Perelman School of Med at the University of Pennsylvania, 1999
Offices
1 location · University Anesthesia Medical Group · 402 clinicians in this group
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Calfee’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75082 · Current
Licensed to practise in California · since 2001 · expires 2028-10-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Pulmonary Disease
Original Medicare doctor bills
$7,100
Medicare paid this office $7,100 for 29 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 21 | $6,080 | $184 |
Who their Medicare patients are
29 Original Medicare patients in 2024. Average age 74 · Women 52% · Also on Medicaid 41% · Health risk score 3.45. Above the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Chronic kidney disease 52% · COPD 48% · Diabetes 45% · Coronary heart disease 45% · Heart failure 45% · Atrial fibrillation 45% · Dementia 38%.
The office billed $59,092, Medicare allowed $8,902 and paid $7,100; for 46 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 29 | 46 | 74 | 3.45 | $59,092 | $7,100 |
| 2023 | 25 | 71 | 73 | 2.80 | $86,971 | $10,605 |
| 2022 | 35 | 96 | 71 | 3.73 | $130,717 | $16,536 |
| 2021 | 38 | 140 | 67 | 4.06 | $176,857 | $23,419 |
| 2020 | 41 | 120 | 73 | 3.95 | $128,567 | $18,012 |
| 2019 | 21 | 75 | 68 | 3.00 | $78,933 | $11,309 |
| 2018 | 36 | 97 | 70 | 3.27 | $54,064 | $9,601 |
| 2017 | 57 | 160 | 68 | 3.64 | $98,188 | $17,491 |
| 2016 | 49 | 155 | 68 | 3.57 | $124,973 | $20,574 |
| 2015 | 67 | 208 | 70 | 2.83 | $164,898 | $27,321 |
| 2014 | 76 | 237 | 71 | 2.73 | $221,813 | $35,755 |
| 2013 | 70 | 212 | 66 | 3.15 | $209,958 | $34,445 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Critical care, first 30-74 minutes | 20 | $8,147 | $189 |
2022: 1 service
| Critical care, first 30-74 minutes | 34 | $15,126 | $191 |
2021: 1 service
| Critical care, first 30-74 minutes | 29 | $20,673 | $193 |
2020: 2 services
| Critical care, first 30-74 minutes | 32 | $13,955 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,876 | $94 |
2019: 1 service
| Critical care, first 30-74 minutes | 18 | $8,587 | $195 |
2018: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $6,022 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $970 | $65 |
2017: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $10,540 | $93 |
| Critical care, first 30-74 minutes | 15 | $5,090 | $196 |
2016: 2 services
| Critical care, first 30-74 minutes | 21 | $12,264 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $7,378 | $92 |
2015: 3 services
| Critical care, first 30-74 minutes | 33 | $17,170 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,353 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,017 | $65 |
2014: 3 services
| Critical care, first 30-74 minutes | 56 | $28,871 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,527 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,589 | $65 |
2013: 3 services
| Critical care, first 30-74 minutes | 61 | $30,286 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,524 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $872 | $62 |
Money from drug and device companies
$1,800 in 2025
| 2025 | 1 | 1 | $1,800 | $1,800 |
| 2024 | 3 | 10 | $8,145 | $9,518 |
| 2023 | 1 | 1 | $1,500 | $1,500 |
| 2021 | 1 | 1 | $2,400 | $2,400 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boehringer Ingelheim International GmbH | None | $1,800 | 1 payment
|
See the published payment
| Boehringer Ingelheim International GmbH | Consulting · 2025-10-04 | None | $1,800 |
See earlier years (2024, 2023, 2021)
2024: $9,518
| Merck Sharp & Dohme | None | $7,418 | 8 payments
|
| Aero US | Aerogen Solo Nebulizer System | $1,500 | 1 payment
|
| Boehringer Ingelheim International GmbH | Ofev | $600 | 1 payment
|
2023: $1,500
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $1,500 | 1 payment
|
2021: $2,400
| Janssen Research & Development | None | $2,400 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Genentech, Inc. · UCSF-Genentech Research Collaboration on the Earli Cohort · 2019 | Their institution | $1,663,000 |
| Amgen Inc. · I-Spy Covid Trial: An Adaptive Platform Trial To Reduce Mortality and Ventilator Requirements for Critically Ill Patients · 2020 | Their institution | $689,000 |
| Takeda Pharmaceuticals U.S.A., Inc. · Firazyr · 2020 | Their institution | $653,000 |
| Genentech, Inc. · Task Order Identifying Treatable Targets in Ards · 2020 | Their institution | $608,000 |
| Amgen Inc. · I-Spy Covid Trial: An Adaptive Platform Trial To Reduce Mortality and Ventilator Requirements for Critically Ill Patients · 2021 | Their institution | $412,033 |
| Genentech, Inc. · Ards Earli Cohort Collaboration · 2021 | Their institution | $371,190 |
| Genentech, Inc. · Pre Clinical0122022 · 2022 | Their institution | $302,069 |
| Genentech, Inc. · Preclinical07222022 · 2022 | Their institution | $302,069 |
Professional record
- NPI
- 1245338649
- Licence
- CA A75082California A75082: Current · expires 2028-10-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 1999 · 27 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 505 Parnassus Avenue, Hsw 825, Box 0130 C/O Matthay Lab, San Francisco, CA, 94143
- NPI first listed
- 2006-09-20
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.